Annual report pursuant to Section 13 and 15(d)

Stockholders' Deficit (Details Narrative)

Stockholders' Deficit (Details Narrative) - USD ($)										8 Months Ended	12 Months Ended
Stockholders' Deficit (Details Narrative) - USD ($)	Sep. 19, 2019	Nov. 05, 2018	Jul. 23, 2018	Jul. 20, 2018	Jun. 28, 2018	Sep. 27, 2017	Sep. 21, 2017	Aug. 14, 2017	Feb. 07, 2017	Sep. 10, 2019	Dec. 31, 2018	Dec. 31, 2017	Sep. 18, 2018	May 09, 2018
Common stock par value											$ 0.0001	$ 0.0001	$ 0.0001
Common stock shares authorized											10,000,000,000	10,000,000,000	10,000,000,000
Preferred stock shares authorized											5,000,000		5,000,000
Preferred stock par value											$ 0.01		$ 0.01
Conversion of stock into shares											20,000,000
Number of common stock issued on conversion											$ 8,128,044	$ 7,306,314
Number of common stock issued, valuie											$ 4,619,150
Common stock shares issued											128,567,273	39,502
Common stock shares outstanding											128,567,273	39,502
Recognized stock stock-based compensation											$ 285,992	$ 303,046
Reserve stock split, description		1-for-500 reverse stock split					1-for-15 reverse stock split		1-for-30 reverse stock split
2007 Equity Plan [Member]
Stock option expense											$ 100,000	200,000
Weighted average period											7 years 3 months 19 days
Intrinsic value of options exercisable											$ 0	0
Remaining stock option expense											$ 34,600
Subsequent Event [Member]
Number of shares converted										7,380,369,502
Common stock shares outstanding										7,508,936,775
Reserve stock split, description	Specific ratio ranging up to 1-for-10,000
Restricted Stock [Member]
Recognized stock stock-based compensation												189,209
Employees and Directors [Member]
Number of restricted stock issued								364
Recognized stock stock-based compensation												$ 244,768
Employees and Directors [Member] \| Restricted Stock [Member]
Number of restricted stock issued											142,667
Recognized stock stock-based compensation											$ 477,933
Number of restricted stock shares forfeited											122
Stock issued price per share											$ 3.35
Common Stock [Member]
Common stock shares authorized														3,000,000,000
Number of shares converted											106,335,991
Shares converted into debt											4,221,601	36,571
Number of common stock issued on conversion											$ 422	$ 4
Number of common stock issued											17,788,579
Number of common stock issued, valuie											$ 1,779
Number of restricted stock issued											142,667	364
Common Stock [Member] \| March 2017 Debentures [Member]
Shares converted into debt											4,221,601
Number of common stock issued on conversion											$ 6,700,000
Common stock shares issued											17,788,579
Cashless exercise warrants											106,006,177
Warrants [Member]
Number of warrants isssued as anti-dilution provision											53,234,923,889
Minimum [Member]
Common stock par value													0.0001
Maximum [Member]
Common stock par value													$ 0.01
Series G Preferred Stock [Member]
Preferred stock shares authorized											14,000	14,000
Preferred stock par value											$ 0.01	$ 0.01
Preferred stock shares outstanding											215	215
Preferred stock, stated value											$ 1,000
Weighted average common stock price percentage											85.00%
Shares converted into debt
Number of common stock issued on conversion
Number of common stock issued
Number of common stock issued, valuie
Series H Preferred Stock [Member]
Preferred stock shares authorized											14,202	14,202
Preferred stock par value											$ 0.01	$ 0.01
Preferred stock shares outstanding											10	60
Preferred stock, stated value											$ 1,000
Weighted average common stock price percentage											85.00%
Number of preferred stock converted					50							7,785
Conversion of stock into shares					40,000						50	742
Number of shares converted											40,000
Shares converted into debt												2,174
Number of common stock issued on conversion												$ 2,200,000
Principal amount of debt converted into shares												$ 2,700,000
Series F Convertible Preferred Stock [Member]
Preferred stock shares outstanding											1,750,000
Series F Convertible Preferred Stock [Member] \| Genomas, Inc [Member]
Conversion of stock into shares						120
Number of common stock issued						1,750,000
Number of common stock issued, valuie						$ 174,097
Stock conversion share price						$ 14,625
Preferred stock price per share for unpaid dividend						$ 1.95
Series J Convertible Preferred Stock [Member]
Preferred stock shares outstanding											250,000
Number of common stock issued				250,000
Series J Convertible Preferred Stock [Member] \| Alcimede LLC [Member]
Preferred stock, stated value			$ 1.00
Number of common stock issued			250,000
Number of common stock issued, valuie			$ 250,000
Preferred stock voting rights			Each share of the Series J Preferred Stock had the whole number of votes equal to 24 shares of common stock. With respect to all other matters, and from and after October 1, 2018, each share of the Series J Preferred Stock is entitled to the whole number of votes equal to the number of common shares into which it is then convertible.
Cumulative dividends percentage			8.00%
Series J Convertible Preferred Stock [Member] \| Alcimede LLC [Member] \| Minimum [Member]
Preferred stock shares authorized			3,000,000,000
Series J Convertible Preferred Stock [Member] \| Alcimede LLC [Member] \| Maximum [Member]
Preferred stock shares authorized			10,000,000,000
Series I-2 Preferred Stock [Member]
Number of shares converted											106,335,991
Number of common stock issued on conversion											$ 1,500,000
Series I-2 Preferred Stock [Member] \| Common Stock [Member]
Conversion of stock into shares											1,286.141
Number of shares converted											106,335,991